- Home
- STRO vs PROP Comparison
STRO vs PROP Comparison
Compare STRO & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | PROP |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 93.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | STRO | PROP |
|---|---|---|
| Price | $18.50 | $1.75 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $18.88 | $6.75 |
| AVG Volume (30 Days) | 117.6K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,939,000.00 |
| Revenue This Year | $63.08 | $3,546.93 |
| Revenue Next Year | N/A | $84.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 413.59 |
| 52 Week Low | $0.52 | $1.57 |
| 52 Week High | $19.90 | $7.77 |
Technical Indicators
Market Signals| Indicator | STRO | PROP |
|---|---|---|
| Relative Strength Index (RSI) | 65.21 | 48.41 |
| Support Level | $0.73 | $1.66 |
| Resistance Level | N/A | $1.93 |
| Average True Range (ATR) | 1.84 | 0.11 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 76.17 | 27.16 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.